Now I have thorough comparisons. Let me synthesize the final review.

**Calibration summary:**
- GenoAgent (4.00, Reject): LLM agents for gene expression. Our paper is stronger — cleaner method, more systematic Stage 1, more novel idea.
- LLM4GRN (4.33, Reject): LLMs for GRN discovery. Similar evaluation challenges (no ground truth). Our paper is comparable or slightly better.
- ZerOmics (4.67, Reject): LLMs for zero-shot single-cell. Has more experiments but fundamental framing flaw. Our paper is in a similar tier.
- Gene benchmark (4.75, Reject): Different type (benchmark). Our paper has higher novelty.
- TeDeSC (5.40, Reject): LLMs for semantic clustering of images. Has ground-truth benchmarks and rigorous evaluation our paper lacks. Our paper is weaker.
- BioDiscoveryAgent (6.40, Accept): Strong LLM agent paper with rigorous baselines, ground truth, multi-dataset validation. Our paper is clearly weaker.

**Final score: 4.5 — Reject.** The novel core idea and systematic Stage 1 benchmark are genuine strengths, but the major evaluation gaps (no ground truth for resolution selection, unsupported superiority claims, unvalidated annotations, no LLM ablation) prevent the paper from reaching the 5+ tier where methodological contributions with solid evaluation land.

---

## Summary

This paper proposes HYPOGENEAGENT, an LLM-based framework that annotates gene clusters from single-cell/Perturb-seq data with GO terms and uses the semantic consistency of those annotations — intra-cluster agreement (ICS) and inter-cluster distinctiveness (ICD) — to select the optimal Leiden clustering resolution via a combined Resolution Score. The method is evaluated in two stages: (1) a prompt/model/embedding benchmark on 100 curated GOBP gene sets, and (2) resolution selection on a public K562 CRISPRi Perturb-seq dataset, with comparisons against silhouette score, modularity, and GO enrichment analysis.

## Strengths

- **Novel conceptual bridge between annotation and resolution selection**: The paper introduces the idea of using LLM-generated annotation consistency as an optimization criterion for clustering hyperparameter selection. As noted in the related work (line 37), prior approaches treat annotation as post-hoc; none feeds functional feedback back into clustering parameters. The ICS, ICD, and RS formalization (Section 3.4) makes this idea operational.

- **Systematic Stage 1 parameter benchmark**: Section 4.3 ablates model choice (GPT-4o, GPT-o3, GPT-5, Gemini variants), prompt design (general V1/V2, hypothesis), embedding method (OpenAI, SapBERT, Nomic), and temperature. The finding that top-1 ranked hypotheses from GPT-o3 achieve the highest median cosine similarity against curated GOBP ground truth validates the model's self-ranking ability and justifies the final configuration choice.

- **Dual-space application**: The method is demonstrated at both gene-expression (GEX) and perturbation-target levels on the same dataset, showing the framework adapts to different cluster definitions while producing consistent, interpretable optimal resolutions.

- **Interpretable metric decomposition**: Figures 3c/d and 4c/d separately plot ICS and ICD across resolutions, making the Resolution Score's behavior transparent rather than a black-box aggregation.

## Weaknesses

### Fatal

None.

### Major

- **Unsupported claims of superiority over traditional methods**: The paper claims the Resolution Score "exceeded traditional metrics such as modularity, silhouette score and functional enrichment analysis" (line 261) and "recovers known perturbation effects better than modularity and silhouette criteria" (line 25). The evaluation provides no ground truth for what constitutes a correct clustering resolution — there is no dataset with known cluster structure, no expert-annotated reference clustering, and no benchmark of which perturbation effects should be recovered at which resolution. The comparison in Section 4.4 shows different methods select different resolutions (silhouette: r=0.5–0.6, modularity: r=0.7, GO enrichment: r=0.4–0.5, HYPOGENEAGENT: r=0.4–0.5), but without an independent correctness criterion, no method can be shown to outperform another. This is a structural gap in the evaluation design.

- **GO enrichment baseline undermines the LLM contribution claim**: Section 4.4.3 applies the same ICS/ICD/RS framework to standard GO enrichment results and finds resolution selections (r=0.4–0.5) consistent with HYPOGENEAGENT's. The paper interprets this as validation (line 259), but it equally supports the interpretation that the LLM adds nothing beyond what standard enrichment provides. The paper never ablates the LLM component to isolate its contribution — a critical gap given that the headline contribution is specifically the LLM agent.

- **Annotation quality on Perturb-seq data is never validated**: The entire pipeline rests on the assumption that the LLM produces accurate GO annotations for Perturb-seq cluster gene signatures. This is tested only on 100 clean, curated GOBP gene sets (Stage 1), where absolute performance is modest (AUC=0.743, median cosine similarity ~0.4–0.5). Perturb-seq cluster signatures are noisier and often lack a single clean biological interpretation. The paper provides no validation of annotation quality on the target data — not a single Perturb-seq cluster annotation is checked against expert judgment or known perturbation mechanisms from the Replogle et al. dataset.

- **ICS may conflate LLM output consistency with biological coherence**: Intra-cluster agreement measures how similar the LLM's top-5 hypotheses are within a cluster and interprets high ICS as evidence of biological coherence. But an LLM that defaults to producing thematically narrow hypotheses — or collapses to vague, high-level processes under uncertainty — will yield high ICS regardless of cluster biology. The paper provides no evidence that ICS correlates with orthogonal measures of cluster quality (e.g., cell-level silhouette scores, marker-gene homogeneity), leaving open the possibility that the metric measures LLM output behavior rather than biological signal.

### Minor

- **Clustering procedure underspecified in main text**: Section 3.2 describes the clustering pipeline in a single sentence deferring entirely to the appendix for scaling method, dimensionality reduction approach, number of components, distance metric, and kNN construction parameters.

- **Weight sensitivity analysis relegated to appendix**: The Resolution Score uses w=1/3, chosen by "a small grid search." The sensitivity of optimal resolution to w is only in Figure S5 (appendix). The main text (line 237) notes that "those outliers can be the key clusters to be explored further in biology level" — a vague post-hoc observation rather than a systematic sensitivity analysis.

- **Single dataset limits generalizability evidence**: The resolution selection evaluation uses only one K562 CRISPRi Perturb-seq dataset. Broader claims about generalizability (line 265: "general-purpose tool for single-cell, perturb-seq and multi-omics analyses") exceed what a single dataset can support.

### Trivial

- **Overclaiming in framing**: The abstract claims the method "establish[es] LLM agents as objective adjudicators of cluster resolution" — a strong assertion given the single-dataset evaluation and absence of ground truth. The framing escalates from measured claims (abstract: "exhibit alignment") to unsupported ones (conclusion: "exceeded traditional metrics").

- **"Agent" framing is stretched**: Despite positioning within the AI-for-science agent narrative with extensive citation of multi-step interactive agent systems, the system is essentially a prompted LLM with retrieval — not an interactive agent that plans experiments or iterates.

## Nice-to-Haves

- Correlating ICS against cell-level cluster quality metrics (e.g., silhouette width, differential expression sharpness) would strengthen the claim that ICS captures biological signal rather than LLM output artifacts.
- Validating a sample of Perturb-seq cluster annotations against expert judgment or known CRISPR target mechanisms would close the evidential loop between Stage 1 and Stage 2.
- Ablating the LLM by comparing Resolution Score using (a) LLM annotations, (b) standard GO enrichment terms embedded the same way, and (c) random term assignment would isolate the LLM's contribution.
- Evaluating on a dataset with known ground-truth cluster structure (e.g., simulated data or expert-annotated reference) would enable rigorous comparison against classical metrics.

## Removed Points

These points are flagged to be removed, treat them with caution:

- **Harsh Critic: "the paper omits discussion of work on using embedding-based semantic similarity for evaluating biological annotations"** — REMOVED per hard rule: missing related works cannot be verified to exist or be relevant.

- **Harsh Critic: "does not critically engage with the limitations of LLM-based gene-set annotation that Hu et al. (2025) and Wang et al. (2025) have documented"** — REMOVED: the paper cites these works and is not required to reproduce their limitation analyses; this is scope creep.

- **Harsh Critic: "no error bars, confidence intervals, or variance estimates appear for the resolution score curves"** — REMOVED: the paper uses box plots (Figures 3, 4, 6) which inherently display quartiles and range; demanding confidence intervals on top is not standard practice.

- **Harsh Critic: "Figure 3b shows a UMAP at r=0.4, not a comparison of UMAPs across resolutions. Figure S4 (appendix) apparently shows all UMAPs, but is not available."** — REMOVED per hard rule: the appendix is stripped by the parser and exists in the original submission.

- **Harsh Critic: "The retrieval tool is described in one sentence (line 53) but is central to the agent's knowledge. What databases are queried? How are snippets selected and formatted?"** — REMOVED as a reproducibility nitpick; the paper states the databases (GO, KEGG, PubMed) at line 53, and full implementation details belong in the appendix.

- **Strength Finder: "Up-to-date biological knowledge, reduced human bias, seamless resolution selection" listed as advantages** — REMOVED as a claimed strength. These are aspirational claims from the conclusion (line 265), not independently demonstrated contributions.

- **Strength Finder: "Reduced human bias and higher throughput"** — REMOVED: these are claimed but not measured or demonstrated.

## Novel Insights

None beyond the paper's own contributions. The core idea of closing the loop between annotation and clustering resolution using consistency metrics is genuinely novel. However, the reviews do not surface insights about the paper that the paper itself does not already claim.

## Suggestions

- Reframe the contribution honestly: the paper demonstrates that annotation-consistency metrics produce *different* resolution selections from classical metrics and are *consistent* with GO enrichment, which is a meaningful contribution without claiming unproven superiority. The "exceeded" and "better than" claims should be removed or softened to "provides a complementary, biology-aware criterion."
- The GO enrichment consistency result (Section 4.4.3) should be reframed: rather than claiming it validates the LLM agent specifically, acknowledge that it validates the ICS/ICD/RS framework while leaving open whether the LLM adds value beyond enrichment.
- Add an LLM ablation experiment, even on a smaller scale, to isolate whether the LLM's semantic reasoning provides signal beyond what standard enrichment captures.

## Score and Decision

### Calibration Anchors

| Anchor | Avg Score | Round | Comparison |
|--------|-----------|-------|------------|
| scMPT (nUpM7egYFd) | 3.40 | R1 Low | Weaker: different domain, less novel |
| scKGOT (Y9yQ9qmVrc) | 2.50 | R1 Low | Weaker: different problem, less novel |
| GenoAgent (v7aeTmfGOu) | 4.00 | R1 Mid / R2 | Our paper is stronger: cleaner method, more systematic ablation, more novel idea |
| LLM4GRN (jLd7OyAD4Y) | 4.33 | R2 | Our paper is comparable or slightly better: similar evaluation challenges but more novel framework |
| ZerOmics (J1xtkJmFY3) | 4.67 | R1 Mid / R2 | Our paper is comparable: ZerOmics has broader experiments but fundamental framing flaw; our paper has cleaner method |
| Gene benchmark (GDDqq0w6rs) | 4.75 | R2 | Different types; our paper has higher novelty but weaker evaluation |
| TeDeSC (PhRYDGqiee) | 5.40 | R2 | Our paper is weaker: TeDeSC has ground-truth benchmarks, rigorous metrics, and multi-dataset evaluation |
| BioDiscoveryAgent (HAwZGLcye3) | 6.40 | R1 Mid | Our paper is clearly weaker: BioDiscoveryAgent has ground truth, rigorous baselines, multi-dataset validation, 21% improvement |

**Round 1 bracket: 3.5 – 5.5**. Round 2 narrowed to approximately 4.0–5.0 range via comparison with GenoAgent (4.00), LLM4GRN (4.33), ZerOmics (4.67), Gene benchmark (4.75), and TeDeSC (5.40). The paper is clearly stronger than GenoAgent (4.00), comparable to LLM4GRN/ZerOmics (4.3–4.7), and weaker than TeDeSC (5.40) which has ground-truth evaluation. The novel core idea and systematic Stage 1 benchmark warrant a score above the 4.0 tier, but the major evaluation gaps (no ground truth, unsupported superiority claims, no LLM ablation, unvalidated annotations) prevent reaching 5.0+.

**Final score: 4.5 — Reject.**

MY FINAL SCORE: <score>4.5</score>
MY FINAL DECISION: <decision>Reject</decision>